de simone formulation probiotic formula manufacturing method developed claudio de de simone formulation clinically studied variety health conditions since researched efficacy medical management chronic intestinal conditions including irritable bowel syndrome inflammatory bowel disease de simone formulation subject lawsuits united states us circuit court appeals upheld false advertising verdict makers probiotic february stating enough evidence support jurys november finding makers quote reverseengineered imperfect copy de simones signature probiotic formulation sold brand name may withdrew joint venture vsl pharmaceuticals inc according lawsuit departure result pressured substitute cheaper bacteria manufacturing process lower production costs raise court action states de simone apparently makers ordered pay de simone exegi pharma combined total million usd court also issued permanent injunction intended prevent claims implied stated continuity two different formulations court also cited public health wellbeing concerns blocked makers linking product original de simone formulation referring clinical studies executed using de simone formulation prior may august american gastroenterology association aga medical association gastroenterologists united states issued correction regarding de simone formulation agas correction stated referenced studies referenced technical review management mildtomoderate ulcerative colitis based probiotic formulation previously know brand name may known formulation name de simone january european crohns colitis organization ecco issued letter editor oxford academics journal crohns colitis jcc stating result court injunction ecco must provide clarification note changes relating de simone formulation articles reference studied httpsenwikipediaorgwikidesimoneformulation